Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Fischer-Valuck

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Brachytherapy|August 21, 2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancerVishal R Dhere, Benjamin W Fischer-Valuck, Subir Goyal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy deviceLauren E Henke, Benjamin W Fischer-Valuck, Soumon Rudra, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
European Urology Open Science|March 4, 2022
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate CancerBenjamin W Fischer-Valuck, Brian C Baumann, Simon A Brown, et al.
European Urology Oncology|March 7, 2022
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic ChemotherapyBenjamin W Fischer-Valuck, Sagar A Patel, Randall J Brenneman, et al.
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Advances in Radiation Oncology|November 9, 2017
Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy systemBenjamin W Fischer-Valuck, Lauren Henke, Olga Green, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2017
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III TrialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Clinical and Translational Radiation Oncology|January 19, 2019
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer DatabaseBenjamin W Fischer-Valuck, Jeff M Michalski, Jessika A Contreras, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Brachytherapy|August 21, 2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancerVishal R Dhere, Benjamin W Fischer-Valuck, Subir Goyal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy deviceLauren E Henke, Benjamin W Fischer-Valuck, Soumon Rudra, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
European Urology Open Science|March 4, 2022
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate CancerBenjamin W Fischer-Valuck, Brian C Baumann, Simon A Brown, et al.
European Urology Oncology|March 7, 2022
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic ChemotherapyBenjamin W Fischer-Valuck, Sagar A Patel, Randall J Brenneman, et al.
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Advances in Radiation Oncology|November 9, 2017
Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy systemBenjamin W Fischer-Valuck, Lauren Henke, Olga Green, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2017
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III TrialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Clinical and Translational Radiation Oncology|January 19, 2019
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer DatabaseBenjamin W Fischer-Valuck, Jeff M Michalski, Jessika A Contreras, et al.
Pageof 6